이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Ambu 배당금

배당금 기준 확인 0/6

Ambu 현재 배당금을 지급하지 않습니다.

주요 정보

배당 수익률

지급 비율

업계 평균 수익률	1.7%
다음 배당금 지급일	n/a
전 배당일	n/a
주당 배당금	n/a
주당 순이익	DKK 1.38
3년 후 배당 수익률 예측	0.4%

최근 배당금 업데이트

Recent updates

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Apr 06

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Mar 14

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

Feb 01

결제의 안정성과 성장

배당금 데이터 가져오기

안정적인 배당: 과거에 AMBU B 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.

배당금 증가: AMBU B 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.

시장 대비 배당 수익률

Ambu 시장 대비 배당 수익률

AMBU B 배당 수익률은 시장과 어떻게 비교되나요?
세그먼트	배당 수익률
회사 (AMBU B)	0%
시장 하위 25% (DK)	1.7%
시장 상위 25% (DK)	5.7%
업계 평균 (Medical Equipment)	1.7%
3년 후 애널리스트 예측 (AMBU B)	0.4%

주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 AMBU B 의 배당 수익률을 평가할 수 없습니다.

고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 AMBU B 의 배당 수익률을 평가할 수 없습니다.

주주에 대한 수익 배당금

수익 보장: AMBU B Danish 시장에서 주목할만한 배당금을 지급하지 않습니다.

주주에 대한 현금 배당금

현금 흐름 범위: AMBU B 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.

Ambu 배당금

배당금 기준 확인 0/6

주요 정보

최근 배당금 업데이트

Upcoming dividend of kr.0.29 per share

Recent updates

Consensus EPS estimates increase by 14%

Second quarter 2024 earnings: EPS misses analyst expectations

Ambu A/S' (CPH:AMBU B) Subdued P/S Might Signal An Opportunity

Returns On Capital Signal Tricky Times Ahead For Ambu (CPH:AMBU B)

Results: Ambu A/S Exceeded Expectations And The Consensus Has Updated Its Estimates

First quarter 2024 earnings released

Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24

Price target increased by 10% to kr.101

Price target increased by 7.2% to kr.91.83

A Piece Of The Puzzle Missing From Ambu A/S' (CPH:AMBU B) Share Price

Ambu A/S Elects Shacey Petrovic as Vice Chair of Board of Directors

Ambu A/S Announces Henrik Ehlers Wulff Not to Run for Re-Election for Board of Directors

Ambu A/S Provides Earnings Guidance for the Full-Year 2023/24

Price target decreased by 9.0% to kr.87.00

Is Ambu A/S (CPH:AMBU B) Trading At A 42% Discount?

Ambu A/S Appoints Henrik Skak Bender as Member of the Executive Management, Effective 1 January 2024

Ambu A/S Announces Chief Financial Officer Changes

Ambu A/S to Report Q2, 2024 Results on May 14, 2024

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Ambu A/S Narrows Earnings Guidance for the Full-Year 2022/23

Third quarter 2023 earnings released

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

Does This Valuation Of Ambu A/S (CPH:AMBU B) Imply Investors Are Overpaying?

Ambu A/S Raises Earnings Guidance for the Full-Year 2022/2023

New minor risk - Share price stability

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Ambu (CPH:AMBU B) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: Revenues in line with analyst expectations

Price target decreased by 8.7% to kr.95.50

Returns On Capital At Ambu (CPH:AMBU B) Paint A Concerning Picture

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Price target increased by 16% to kr.96.80

First quarter 2023 earnings released: EPS: kr.0.09 (vs kr.0.08 in 1Q 2022)

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Ambu (CPH:AMBU B) Will Be Hoping To Turn Its Returns On Capital Around

High number of new directors

Ambu A/S Provides Earnings Guidance for the Financial Year of 2022-2023

Full year 2022 earnings: Revenues in line with analyst expectations

Consensus forecasts updated

Ambu A/S to Report Q3, 2023 Results on Aug 31, 2023

Is Ambu A/S (CPH:AMBU B) Trading At A 30% Discount?

Ambu A/S(CPSE:AMBU B) dropped from FTSE All-World Index (USD)

Ambu (CPH:AMBU B) Will Want To Turn Around Its Return Trends

Now 20% undervalued after recent price drop

Price target decreased to kr.76.50

Third quarter 2022 earnings: Revenues in line with analyst expectations

Ambu A/S Reaffirms Earnings Guidance for the Full-Year 2021/2022

We Think Ambu (CPH:AMBU B) Is Taking Some Risk With Its Debt

Consensus forecasts updated

Ambu A/S Revises Earnings Guidance for the Full-Year 2021/2022

Ambu Announces FDA Clearance of Fifth-Generation Single-Use Bronchoscope

Investor sentiment deteriorated over the past week

Ambu (CPH:AMBU B) Could Be Struggling To Allocate Capital

Price target decreased to kr.94.25

Ambu A/S Reaffirms Earnings Guidance for the Fiscal Year 2021/22

These 4 Measures Indicate That Ambu (CPH:AMBU B) Is Using Debt Extensively

Consensus forecasts updated

Second quarter 2022 earnings: Revenues in line with analyst expectations

Price target decreased to kr.137

Less than half of directors are independent

First quarter 2022 earnings: EPS misses analyst expectations

Ambu A/S Revises Revenue Guidance for the Fiscal 2022

Ambu Announces FDA Clearance of Single-Use Gastroscope and Next-Generation Display Unit

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Are Investors Undervaluing Ambu A/S (CPH:AMBU B) By 27%?

Upcoming dividend of kr.0.29 per share

Full year 2021 earnings released: EPS kr.0.98 (vs kr.0.98 in FY 2020)

Does Ambu (CPH:AMBU B) Have A Healthy Balance Sheet?

Price target decreased to kr.169

Third quarter 2021 earnings released

Price target decreased to kr.193